| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |